The ProtecT trial: what can we expect?

Affiliations

¹ Department of Urology, Erasmus University Medical Center, PO Box 2040, 3000 CA Rotterdam, Netherlands. Electronic address: m.roobol@erasmusmc.nl.
² Department of Urology, Erasmus University Medical Center, PO Box 2040, 3000 CA Rotterdam, Netherlands.

Free article

Comment

Monique J Roobol et al. Lancet Oncol. 2014 Sep.

Free article

. 2014 Sep;15(10):1046-7.

doi: 10.1016/S1470-2045(14)70198-6. Epub 2014 Aug 19.

¹ Department of Urology, Erasmus University Medical Center, PO Box 2040, 3000 CA Rotterdam, Netherlands. Electronic address: m.roobol@erasmusmc.nl.
² Department of Urology, Erasmus University Medical Center, PO Box 2040, 3000 CA Rotterdam, Netherlands.

Erratum in

No abstract available

Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial.
Lane JA, Donovan JL, Davis M, Walsh E, Dedman D, Down L, Turner EL, Mason MD, Metcalfe C, Peters TJ, Martin RM, Neal DE, Hamdy FC; ProtecT study group. Lane JA, et al. Lancet Oncol. 2014 Sep;15(10):1109-18. doi: 10.1016/S1470-2045(14)70361-4. Epub 2014 Aug 19. Lancet Oncol. 2014. PMID: 25163905 Clinical Trial.